BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20615068)

  • 1. Proangiogenic cytokines vascular-endothelial growth factor and basic fibroblst growth factor in childhood lymphadenopathy.
    Mizia-Malarz A; Sobol G; Musioł K; Janowska J; Zahorska-Markiewicz B; Wos H
    Pediatr Hematol Oncol; 2010 Aug; 27(5):393-404. PubMed ID: 20615068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of proangiogenic cytokines in children with lymphomas.
    Mizia-Malarz A; Sobol G; Janowska J; Wos H; Zahorska-Markiewicz B
    Pediatr Blood Cancer; 2009 Dec; 53(7):1195-9. PubMed ID: 19621434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
    Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H; Wierzbowska A; Robak T
    Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
    Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
    Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?
    Dincaslan HU; Yavuz G; Unal E; Tacyildiz N; Ikinciogullari A; Dogu F; Guloglu D; Yuksek N; Ertem U
    Pediatr Hematol Oncol; 2010 Oct; 27(7):503-16. PubMed ID: 20677920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy.
    Andrys C; Borska L; Pohl D; Fiala Z; Hamakova K; Krejsek J
    Arch Dermatol Res; 2007 Mar; 298(10):479-83. PubMed ID: 17221216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come.
    Aref S; El Sherbiny M; Goda T; Fouda M; Al Askalany H; Abdalla D
    Hematology; 2005 Apr; 10(2):131-4. PubMed ID: 16019458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia.
    Gora-Tybor J; Blonski JZ; Robak T
    Mediators Inflamm; 2003 Jun; 12(3):167-71. PubMed ID: 12857600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma.
    Ho CL; Sheu LF; Li CY
    Ann Diagn Pathol; 2003 Feb; 7(1):1-8. PubMed ID: 12616467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
    Yu XM; Lo CY; Lam AK; Leung P; Luk JM
    Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression.
    Kurschat P; Eming S; Nashan D; Krieg T; Mauch C
    Br J Dermatol; 2007 Apr; 156(4):653-8. PubMed ID: 17263813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours.
    Komorowski J; Jankewicz J; Stepień H
    Cytobios; 2000; 101(398):151-9. PubMed ID: 10755214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in children with hemangiomas and vascular malformations--preliminary report.
    Przewratil P; Sitkiewicz A; Wyka K; Andrzejewska E
    Pediatr Dermatol; 2009; 26(4):399-404. PubMed ID: 19689513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.
    Yu XM; Lo CY; Lam AK; Lang BH; Leung P; Luk JM
    Surgery; 2008 Dec; 144(6):934-40; discussion 940-1. PubMed ID: 19041000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic cytokines in serum and cutaneous lesions of patients with polyarteritis nodosa.
    Kikuchi K; Hoashi T; Kanazawa S; Tamaki K
    J Am Acad Dermatol; 2005 Jul; 53(1):57-61. PubMed ID: 15965421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic effects of surgery: quantitative analysis of circulating basic fibroblast growth factor (bFGF), Vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-beta) in patients with breast cancer who underwent limited or extended surgery.
    Curigliano G; Petit JY; Bertolini F; Colleoni M; Peruzzotti G; de Braud F; Gandini S; Giraldo A; Martella S; Orlando L; Munzone E; Pietri E; Luini A; Goldhirsch A
    Breast Cancer Res Treat; 2005 Sep; 93(1):35-40. PubMed ID: 16184456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.